For which severe childhood epilepsy syndromes has CBD efficacy led to FDA-approved medication?
Answer
Dravet syndrome and Lennox-Gastaut syndrome
Cannabidiol (CBD) has garnered significant clinical interest due to its potential anticonvulsant properties, which appear particularly effective in certain drug-resistant seizure disorders. Clinical success in managing specific, severe forms of childhood epilepsy has been recognized by regulatory bodies. Specifically, CBD has demonstrated efficacy in treating cases of Dravet syndrome and Lennox-Gastaut syndrome. This proven therapeutic value in managing these difficult conditions has resulted in the development and approval of prescription medications derived directly from CBD for these indications.
Related Questions
What are the primary receptor sites engaged by cannabis compounds in the body?Which cannabis compound is responsible for generating the intoxicating high associated with marijuana?How does Cannabidiol (CBD) differ from THC regarding CB1 receptor interaction?Where are CB1 receptors highly concentrated, explaining cannabis's neurological impact?Why might introducing THC during adolescence potentially cause lasting changes in brain structure?What short-term cardiovascular changes can occur from using cannabis with higher THC levels?Which two ingestion methods remove the risk associated with combustion byproducts like tar exposure?For which severe childhood epilepsy syndromes has CBD efficacy led to FDA-approved medication?Under US Federal law, what classification is cannabis given regarding potential for abuse?What specific type of pain, stemming from nerve damage, is THC often considered for relief?